Article ID Journal Published Year Pages File Type
3331842 Hematology/Oncology Clinics of North America 2009 14 Pages PDF
Abstract

The past 15 years have seen rapid advances in both our understanding of hereditary melanoma genetics and the technologies that enable scientists to make discoveries. Despite great efforts by many groups worldwide, other high-risk melanoma loci besides CDKN2A still remain elusive. A panel of polymorphisms that appears to confer low-to-moderate risk for melanoma has been assembled through functional and genome-wide association studies. The goal of personalized melanoma risk prediction is within our reach, although true clinical use has yet to be established.

Related Topics
Health Sciences Medicine and Dentistry Hematology
Authors
, ,